tradingkey.logo

Co-Diagnostics Inc

CODX
2.360USD
0.0000.00%
Close 02/06, 16:00ETQuotes delayed by 15 min
113.62MMarket Cap
LossP/E TTM

Co-Diagnostics Inc

2.360
0.0000.00%

More Details of Co-Diagnostics Inc Company

Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.

Co-Diagnostics Inc Info

Ticker SymbolCODX
Company nameCo-Diagnostics Inc
IPO dateJul 12, 2017
CEOEgan (Dwight H)
Number of employees132
Security typeOrdinary Share
Fiscal year-endJul 12
Address2401 S. Foothill Dr. Suite D
CitySALT LAKE CITY
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code84109
Phone18014381036
Websitehttps://codiagnostics.com/
Ticker SymbolCODX
IPO dateJul 12, 2017
CEOEgan (Dwight H)

Company Executives of Co-Diagnostics Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Richard S. Serbin
Mr. Richard S. Serbin
Independent Director
Independent Director
10.97K
+1917.00%
Mr. James B. Nelson
Mr. James B. Nelson
Independent Director
Independent Director
10.89K
+1917.00%
Mr. Dwight H. Egan
Mr. Dwight H. Egan
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Dr. Eugene Durenard, Ph.D.
Dr. Eugene Durenard, Ph.D.
Independent Director
Independent Director
--
--
Mr. Edward L. (Ted) Murphy
Mr. Edward L. (Ted) Murphy
Independent Director
Independent Director
--
--
Mr. Brian L. Brown, CPA
Mr. Brian L. Brown, CPA
Chief Financial Officer, Company Secretary
Chief Financial Officer, Company Secretary
--
--
Mr. Richard Abbott
Mr. Richard Abbott
President
President
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Richard S. Serbin
Mr. Richard S. Serbin
Independent Director
Independent Director
10.97K
+1917.00%
Mr. James B. Nelson
Mr. James B. Nelson
Independent Director
Independent Director
10.89K
+1917.00%
Mr. Dwight H. Egan
Mr. Dwight H. Egan
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Dr. Eugene Durenard, Ph.D.
Dr. Eugene Durenard, Ph.D.
Independent Director
Independent Director
--
--
Mr. Edward L. (Ted) Murphy
Mr. Edward L. (Ted) Murphy
Independent Director
Independent Director
--
--
Mr. Brian L. Brown, CPA
Mr. Brian L. Brown, CPA
Chief Financial Officer, Company Secretary
Chief Financial Officer, Company Secretary
--
--

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
136.74K
94.06%
Rest of the world
8.64K
5.94%
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Sat, Jan 31
Updated: Sat, Jan 31
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Ayrton Capital LLC
6.14%
The Vanguard Group, Inc.
3.14%
Orca Capital GmbH
3.10%
Private Advisory Group LLC
1.94%
Renaissance Technologies LLC
1.42%
Other
84.26%
Shareholders
Shareholders
Proportion
Ayrton Capital LLC
6.14%
The Vanguard Group, Inc.
3.14%
Orca Capital GmbH
3.10%
Private Advisory Group LLC
1.94%
Renaissance Technologies LLC
1.42%
Other
84.26%
Shareholder Types
Shareholders
Proportion
Investment Advisor
9.65%
Hedge Fund
7.58%
Individual Investor
5.87%
Investment Advisor/Hedge Fund
1.02%
Research Firm
0.44%
Bank and Trust
0.03%
Other
75.41%

Institutional Shareholding

Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
80
11.14M
13.43%
-308.03K
2025Q3
83
11.45M
12.86%
+6.26M
2025Q2
88
5.18M
18.12%
-695.54K
2025Q1
96
5.88M
20.77%
-1.09M
2024Q4
104
5.75M
18.48%
+1.31M
2024Q3
108
4.45M
20.26%
-229.17K
2024Q2
125
4.65M
21.94%
+232.83K
2024Q1
134
4.41M
23.86%
-3.05M
2023Q4
144
4.75M
24.82%
-54.54K
2023Q3
160
4.81M
26.97%
+93.65K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Ayrton Capital LLC
124.61K
6.14%
+124.61K
--
Sep 30, 2025
The Vanguard Group, Inc.
56.87K
2.8%
-910.00
-1.58%
Sep 30, 2025
Orca Capital GmbH
62.86K
3.1%
-10.27K
-14.04%
Oct 28, 2025
Private Advisory Group LLC
39.39K
1.94%
--
--
Sep 30, 2025
Renaissance Technologies LLC
28.92K
1.42%
+10.22K
+54.63%
Sep 30, 2025
Egan (Dwight H.)
28.73K
1.42%
+3.79K
+15.21%
Nov 23, 2025
Abbott (Richard David)
23.22K
1.14%
+1.32K
+6.01%
Nov 23, 2025
Brown (Brian Lee)
23.09K
1.14%
+3.12K
+15.59%
Nov 23, 2025
BlackRock Institutional Trust Company, N.A.
14.25K
0.7%
--
--
Sep 30, 2025
Serbin (Richard S)
10.97K
0.54%
+1.92K
+21.17%
Nov 23, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Micro-Cap ETF
Proportion0%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
Jul 11, 2025
Merger
30→1
Date
Ex-dividend Date
Type
Ratio
Jul 11, 2025
Merger
30→1
KeyAI